| Ticker Details |
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
|
| IPO Date: |
March 26, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$36.05B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.38 | 1.32%
|
| Avg Daily Range (30 D): |
$0.47 | 1.58%
|
| Avg Daily Range (90 D): |
$0.41 | 1.33%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
7.73M |
| Avg Daily Volume (30 D): |
5.99M |
| Avg Daily Volume (90 D): |
7.44M |
| Trade Size |
| Avg Trade Size (Sh.): |
237 |
| Avg Trade Size (Sh.) (30 D): |
110 |
| Avg Trade Size (Sh.) (90 D): |
129 |
| Institutional Trades |
| Total Institutional Trades: |
81,006 |
| Avg Institutional Trade: |
$2.31M |
| Avg Institutional Trade (30 D): |
$4.42M |
| Avg Institutional Trade (90 D): |
$4.36M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
14 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.71M |
| Avg Closing Trade (30 D): |
$18.31M |
| Avg Closing Trade (90 D): |
$17.54M |
| Avg Closing Volume: |
267.96K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$1.23
|
$.42
|
$1.23
|
|
Diluted EPS
|
$1.21
|
$.41
|
$1.21
|
|
Revenue
|
$17.26B
|
$1.5B
|
$17.26B
|
|
Gross Profit
|
$8.94B
|
$2.66B
|
$8.94B
|
|
Net Income / Loss
|
$1.42B
|
$481M
|
$1.42B
|
|
Operating Income / Loss
|
$2.16B
|
$300M
|
$2.16B
|
|
Cost of Revenue
|
$8.32B
|
$2.06B
|
$8.32B
|
|
Net Cash Flow
|
$256M
|
$1.35B
|
$256M
|
|
PE Ratio
|
25.50
|
|
|
| Splits |
|
Jul 01, 2004
|
2:1
|
|
Dec 06, 2002
|
2:1
|
|
Feb 23, 2000
|
2:1
|
|
|
|
